Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 483501, 10 pages
http://dx.doi.org/10.1155/2014/483501
Research Article

Resveratrol Ameliorates Motor Neuron Degeneration and Improves Survival in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis

1Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Ruijin 2nd Road No. 197, Building 11-1201, Shanghai 200025, China
2The Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
3Center for Translational Research of Neurology Disease, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China

Received 11 March 2014; Accepted 16 April 2014; Published 26 June 2014

Academic Editor: Jianzhen Xu

Copyright © 2014 Lin Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Pasinelli and R. H. Brown, “Molecular biology of amyotrophic lateral sclerosis: insights from genetics,” Nature Reviews Neuroscience, vol. 7, no. 9, pp. 710–723, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Chen, P. Sayana, X. Zhang, and W. Le, “Genetics of amyotrophic lateral sclerosis: an update,” Molecular Neurodegeneration, vol. 8, article 28, 2013. View at Google Scholar
  3. X. Zhang, S. Chen, L. Li, Q. Wang, and W. Le, “Decreased level of 5-methyltetrahydrofolate: a potential biomarker for pre-symptomatic amyotrophic lateral sclerosis,” Journal of the Neurological Sciences, vol. 293, no. 1-2, pp. 102–105, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Zhang, S. Chen, L. Li, Q. Wang, and W. Le, “Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1G93A transgenic mice,” Neuropharmacology, vol. 54, no. 7, pp. 1112–1119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Li, X. Zhang, and W. Le, “Altered macroautophagy in the spinal cord of SOD1 mutant mice,” Autophagy, vol. 4, no. 3, pp. 290–293, 2008. View at Google Scholar · View at Scopus
  6. Y. Wu, X. Li, J. X. Zhu et al., “Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease,” NeuroSignals, vol. 19, no. 3, pp. 163–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Vaziri, S. K. Dessain, E. N. Eaton et al., “hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase,” Cell, vol. 107, no. 2, pp. 149–159, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Nemoto, M. M. Fergusson, and T. Finkel, “SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α,” The Journal of Biological Chemistry, vol. 280, no. 16, pp. 16456–16460, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. T. Rodgers, C. Lerin, W. Haas, S. P. Gygi, B. M. Spiegelman, and P. Puigserver, “Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1,” Nature, vol. 434, no. 7029, pp. 113–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Kim, M. D. Nguyen, M. M. Dobbin et al., “SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis,” The EMBO Journal, vol. 26, no. 13, pp. 3169–3179, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. St-Pierre, S. Drori, M. Uldry et al., “Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators,” Cell, vol. 127, no. 2, pp. 397–408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Nemoto, M. M. Fergusson, and T. Finkel, “Nutrient availability regulates SIRT1 through a forkhead-dependent pathway,” Science, vol. 306, no. 5704, pp. 2105–2108, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. E. Gurney, H. Pu, A. Y. Chiu et al., “Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation,” Science, vol. 264, no. 5166, pp. 1772–1775, 1994. View at Google Scholar · View at Scopus
  14. O. A. Andreassen, A. Dedeoglu, A. Friedlich et al., “Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice,” Experimental Neurology, vol. 168, no. 2, pp. 419–424, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. S.-H. Koh, Y. Kim, H. Y. Kim, S. Hwang, C. H. Lee, and S. H. Kim, “Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS,” Experimental Neurology, vol. 205, no. 2, pp. 336–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Misawa, K. Nakata, J. Matsuura et al., “Conditional knockout of Mn superoxide dismutase in postnatal motor neurons reveals resistance to mitochondrial generated superoxide radicals,” Neurobiology of Disease, vol. 23, no. 1, pp. 169–177, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Manabe, I. Nagano, A. Gazi et al., “Glial cell line-derived neurotrophic factor protein prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis,” Neurological Research, vol. 25, no. 2, pp. 195–200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Charles-Schoeman and M. A. Verity, “Nicotinamide adenine dinucleotide tetrazolium reductase identifies microvasculature activation in muscle from adult patients with dermatomyositis,” Journal of Rheumatology, vol. 39, no. 1, pp. 94–99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Amiot, B. Romier, T. M. Dao et al., “Optimization of trans-Resveratrol bioavailability for human therapy,” Biochimie, vol. 95, no. 6, pp. 1233–1238, 2013. View at Publisher · View at Google Scholar
  20. N. Lev, D. Ickowicz, Y. Barhum, E. Melamed, and D. Offen, “DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS,” Journal of Molecular Neuroscience, vol. 38, no. 2, pp. 94–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Muyderman, P. G. Hutson, D. Matusica, M.-L. Rogers, and R. A. Rush, “The human G93A-superoxide dismutase-1 mutation, mitochondrial glutathione and apoptotic cell death,” Neurochemical Research, vol. 34, no. 10, pp. 1847–1856, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Lagouge, C. Argmann, Z. Gerhart-Hines et al., “Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α,” Cell, vol. 127, no. 6, pp. 1109–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Amat, A. Planavila, S. L. Chen, R. Iglesias, M. Giralt, and F. Villarroya, “SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-γ co-activator-1α(PGC-1α) gene in skeletal muscle through the PGC-1α autoregulatory loop and interaction with MyoD,” The Journal of Biological Chemistry, vol. 284, no. 33, pp. 21872–21880, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Higashida, S. H. Kim, S. R. Jung, M. Asaka, J. O. Holloszy, and D. H. Han, “Effects of resveratrol and SIRT1 on PGC-1alpha activity and mitochondrial biogenesis: a reevaluation,” PLOS Biology, vol. 11, no. 7, Article ID e1001603, 2013. View at Google Scholar
  25. W. Zhao, M. Varghese, S. Yemul et al., “Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis,” Molecular Neurodegeneration, vol. 6, no. 1, article 51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. V. A. Lira, C. R. Benton, Z. Yan, and A. Bonen, “PGC-1α regulation by exercise training and its influences on muscle function and insulin sensitivity,” American Journal of Physiology: Endocrinology and Metabolism, vol. 299, no. 2, pp. E145–E161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Irrcher, V. Ljubicic, and D. A. Hood, “Interactions between ROS and AMP kinase activity in the regulation of PGC-1α transcription in skeletal muscle cells,” American Journal of Physiology: Cell Physiology, vol. 296, no. 1, pp. C116–C123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. I. Barrasa, A. Santiago-Gomez, N. Olmo, M. A. Lizarbe, and J. Turnay, “Resistance to butyrate impairs bile acid-induced apoptosis in human colon adenocarcinoma cells via up-regulation of Bcl-2 and inactivation of Bax,” Biochimica et Biophysica Acta, vol. 1823, no. 12, pp. 2201–2209, 2012. View at Publisher · View at Google Scholar
  29. M. Mihara, S. Erster, A. Zaika et al., “p53 has a direct apoptogenic role at the mitochondria,” Molecular Cell, vol. 11, no. 3, pp. 577–590, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Zhang, L. Li, S. Chen et al., “Rapamycin treatment augments motor neuron degeneration in SOD1 G93A mouse model of amyotrophic lateral sclerosis,” Autophagy, vol. 7, no. 4, pp. 412–425, 2011. View at Publisher · View at Google Scholar · View at Scopus